Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Elsayed

Showing results (501-510 of 555) with videos related to

Pageof 56
Sort By:
Pharmaceutics|January 21, 2022
Tailoring of Novel Azithromycin-Loaded Zinc Oxide Nanoparticles for Wound HealingMohammed S Saddik, Mahmoud M A Elsayed, Mohamed A El-Mokhtar, et al.
Pharmaceutics|August 26, 2022
Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical StudyMahmoud M A Elsayed, Moustafa O Aboelez, Mohamed S Mohamed, et al.
European Journal of Human Genetics : EJHG|November 6, 2014
Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancerFadwa A Elsayed, C Marleen Kets, Dina Ruano, et al.
International Journal of Pharmaceutics: X|February 15, 2024
Development and optimization of vildagliptin solid lipid nanoparticles loaded ocuserts for controlled ocular delivery: A promising approach towards treating diabetic retinopathyAbd El Hakim Ramadan, Mahmoud M A Elsayed, Amani Elsayed, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2005
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinomaCarter Van Waes, Angela A Chang, Peter F Lebowitz, et al.
Pediatric Blood & Cancer|December 19, 2019
Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experienceJoshua D Bernstock, Elizabeth Alva, Joshua L Cohen, et al.
Pharmaceutics|October 28, 2023
Characterization and Bio-Evaluation of the Synergistic Effect of Simvastatin and Folic Acid as Wound Dressings on the Healing ProcessMahmoud A Hashem, Badriyah S Alotaibi, Mahmoud M A Elsayed, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2014
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasmsWilliam D Figg, Manish Monga, Donna Headlee, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 2, 2025
Unraveling the therapeutic landscape of miRNAs in pancreatic cancerZeinab A El-Moaty, Maria Wagdy Wasef, Yara A Elsayed, et al.
Pharmaceutics|February 25, 2023
Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon CancerAhmed A El-Shenawy, Mahmoud M A Elsayed, Gamal M K Atwa, et al.
Pageof 56

Showing results (501-510 of 555) with videos related to

Sort By:
Pageof 56
Pharmaceutics|January 21, 2022
Tailoring of Novel Azithromycin-Loaded Zinc Oxide Nanoparticles for Wound HealingMohammed S Saddik, Mahmoud M A Elsayed, Mohamed A El-Mokhtar, et al.
Pharmaceutics|August 26, 2022
Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical StudyMahmoud M A Elsayed, Moustafa O Aboelez, Mohamed S Mohamed, et al.
European Journal of Human Genetics : EJHG|November 6, 2014
Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancerFadwa A Elsayed, C Marleen Kets, Dina Ruano, et al.
International Journal of Pharmaceutics: X|February 15, 2024
Development and optimization of vildagliptin solid lipid nanoparticles loaded ocuserts for controlled ocular delivery: A promising approach towards treating diabetic retinopathyAbd El Hakim Ramadan, Mahmoud M A Elsayed, Amani Elsayed, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2005
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinomaCarter Van Waes, Angela A Chang, Peter F Lebowitz, et al.
Pediatric Blood & Cancer|December 19, 2019
Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experienceJoshua D Bernstock, Elizabeth Alva, Joshua L Cohen, et al.
Pharmaceutics|October 28, 2023
Characterization and Bio-Evaluation of the Synergistic Effect of Simvastatin and Folic Acid as Wound Dressings on the Healing ProcessMahmoud A Hashem, Badriyah S Alotaibi, Mahmoud M A Elsayed, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2014
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasmsWilliam D Figg, Manish Monga, Donna Headlee, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 2, 2025
Unraveling the therapeutic landscape of miRNAs in pancreatic cancerZeinab A El-Moaty, Maria Wagdy Wasef, Yara A Elsayed, et al.
Pharmaceutics|February 25, 2023
Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon CancerAhmed A El-Shenawy, Mahmoud M A Elsayed, Gamal M K Atwa, et al.
Pageof 56